Home » Topics » BioWorld Science

BioWorld Science
RSS

CellCentric enters agreement with PCCTC for phase II dose-expansion study of CCS-1477

April 8, 2020

FDA approves the initiation of stem cell study for protection against COVID-19

April 8, 2020

Phase IIa study of golexanolone shows no clinical benefit

April 8, 2020

Stopping tau in its tracks

April 8, 2020

Minimal phenotyping gives minimal insights into MDD genetics

April 8, 2020

Aviptadil enters clinical trials to treat COVID-19-related ARDS

April 7, 2020

Crinetics reports interim data from phase II ACROBAT EDGE trial of paltusotine in acromegaly

April 7, 2020

PKX-001 demonstrates safety and efficacy in dry eye disease model

April 7, 2020

SARS-CoV-2 vaccine shows promise in first peer-reviewed article on a potential COVID-19 vaccine

April 7, 2020

FDA clears IND application for EIDD-2801 for COVID-19

April 7, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Transcripta Bio raises funding to advance neuro pipeline
BioWorld Science
Transcripta Bio Inc. has raised $24 million since its series A to fund IND-enabling studies across its portfolio and support clinical preparation in its autism...
Daybu readthrough in EU? Zevra’s NPC bid flounders
BioWorld
Zevra Therapeutics Inc. will try to follow in the footsteps of Acadia Pharmaceuticals Inc. with Rett syndrome drug Daybu (trofinetide) by asking the EMA’s...